Vaxinano
Latest round
- Seed
Last raised
- Oct 2024
Total raised
- $6.6M
Investors
- 5
About Vaxinano
Founded in 2016 and headquartered in Loos, France, Vaxinano specializes in producing nasal vaccines and immunotherapies. Didier Betbeder, the CEO and founder, has spearheaded the company's strategy without notable pivots.Vaxinano specializes in developing nasal vaccines and immunotherapies aimed at zoonotic and infectious diseases. Their unique nanoparticle delivery system facilitates crossing mucosal barriers, promoting a swift immune response without adjuvants. The vaccines address challenging pathogens like parasites, viruses, and bacteria, focusing on conditions such as Toxoplasmosis and leishmaniasis.Vaxinano’s revenue model is anchored in strategic partnerships with zoos and conservation organizations, where vaccinations are integrated into wildlife health programs. Collaborations with zoos enable tailored vaccination campaigns, supported by contractual agreements that typically cover supply and ongoing immunization support. Pricing varies based on campaign scale and client requirements, although specific figures are not disclosed. The company is focused on launching new products within these therapeutic areas. Future plans include expanding into additional international markets, although specific regions have not been disclosed.
Who invested in Vaxinano
5 investors across 1 round
See all investors in Vaxinano
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 10, 2024
Amount
$6.6M
Investors
Questions about Vaxinano
Who invested in Vaxinano?
Vaxinano has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaxinano raised?
Vaxinano has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vaxinano last raise money?
Vaxinano's most recent round on record is a Seed, in Oct 2024.
What does Vaxinano do?
Founded in 2016 and headquartered in Loos, France, Vaxinano specializes in producing nasal vaccines and immunotherapies.
Where is Vaxinano headquartered?
Vaxinano is headquartered in Loos, France.
Which VCs invest in companies like Vaxinano?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Vaxinano's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Vaxinano? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.